Press release
Sunovion Pharmaceuticals "LATUDA market size expected to increase many folds by 2032, report DelveInsight
Are you interested in finding out the projected market size of LATUDA in 2032? LATUDA Market Forecast
https://www.delveinsight.com/report-store/latuda-market-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
The LATUDA Market Report offers projected sales forecasts for LATUDA for indications until 2032, categorized across the 7MM i.e. United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The report also provides extensive coverage and a competitive landscape analysis of competitors and marketed products indication. It also covers analyst views along with market drivers and barriers.
Sunovion Pharmaceuticals LATUDA is serving as a beacon of hope for the patients suffering from the Bipolar Depression.
What is a LATUDA Prescribed for?
Sunovion Pharmaceuticals Inc. (Sunovion) declared that the U.S. Food and Drug Administration (FDA) has given approval to the supplemental New Drug Application (sNDA) for Latuda® (lurasidone HCI) to treat schizophrenia in adolescents aged 13 to 17 years. LATUDA is already approved in the U.S. for treating schizophrenia in adults and major depressive episodes linked with bipolar I disorder (bipolar depression) in adults, either as monotherapy or adjunctive therapy with lithium or valproate.
The report extensively covers the details and developments related to LATUDA, capturing important highlights on developmental pipeline, regulatory status and special designations of LATUDA, route of administration, safety and efficacy details.
LATUDA Market Assessment
This report provides a detailed market assessment of LATUDA for Bipolar Depression in the seven major markets, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. This segment of the report provides forecasted sales data from 2028 to 2032.
LATUDA Clinical Assessment
The report provides the clinical trials information of LATUDA for Bipolar Depression covering trial interventions, trial conditions, trial status, start and completion dates. Report also includes important insights on regulatory milestones and other developmental activities related.
Do you know your drug's competitive positioning against LATUDA? LATUDA Drugs Insights
https://www.delveinsight.com/sample-request/latuda-market-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
LATUDA Competitive Landscape
The report offers insights into the key players and companies actively engaged in the development of the specified indication. It provides valuable information regarding the competitive positioning of the LATUDA.
LATUDA Market Size in the US
A dedicated section of the report focuses on the expected market size of LATUDA for the United States. DelveInsight's analysis includes market trends, growth projections, and key factors influencing the market dynamics, offering a comprehensive perspective for stakeholders.
Key Highlights of LATUDA:
• The report contains forecasted sales of LATUDA for indication till 2032.
• Comprehensive coverage of the late-stage emerging therapies for Bipolar Depression.
• The report also features the qualitative and quantitative analysis with analysts as well as KOL views for LATUDA in Bipolar Depression.
Stay ahead in competition by leveraging insights on LATUDA market Report: Download LATUDA Market Report
https://www.delveinsight.com/sample-request/latuda-market-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Why you should buy LATUDA Market Report:
• The report provides future market assessments for LATUDA for Bipolar Depression in the 7 Major Markets, Advance qualitative analysis like SWOT, expert analysts' views, detailed overview of market competitors, and short analysis of other emerging therapies in Ulcerative Colitis.
• Leading LATUDA for Bipolar Depression forecasted market data will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the LATUDA
• Discover the competitive landscape of LATUDA through 7MM
• Get a Thorough Analysis of the LATUDA Development pipeline, Safety & Efficacy of the LATUDA, and ROA
• Thorough LATUDA market forecast will help understand how drug is competing with other emerging LATUDA
• Get analysis of the LATUDA clinical trial advancements and the detailed clinical assessment, regulatory and commercial assessment
• Drug Market forecasts are calculated after taking into consideration KOL viewpoints
Related Reports By DelveInsight:
Bipolar Depression Pipeline https://www.delveinsight.com/report-store/bipolar-depression-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's, "Bipolar Depression Pipeline Insight, 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Bipolar Depression pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. The key Bipolar Depression companies in the market include - Sunovion PharmaceuticalsInc, NRx Pharmaceuticals,Inc., Elevar Therapeutics, Celon Pharma, and others.
It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Top Services Offered By DelveInsight:
Elevate healthcare strategies with Delveinsight Healthcare Consulting. Unlock insights, navigate challenges, and drive success in the dynamic healthcare landscape. https://www.delveinsight.com/consulting
Explore success with our case study on R&D, Manufacturing & Commercial Capabilities. Uncover insights for strategic growth in the industry. https://www.delveinsight.com/case-study/r-and-d-landscape-assessment
Unlock success with our Product Assessment case study. Gain valuable insights for strategic decision-making and product optimization in your industry. https://www.delveinsight.com/case-study/oncology-product-assessment-dashboard
Elevate your business with our Market Assessment case study. Transform insights into strategic actions for success in your industry. https://www.delveinsight.com/case-study/immune-checkpoint-inhibitor-market-potential
Latest Reports Offered By DelveInsight:
Granulomatosis With Polyangiitis Market
https://www.delveinsight.com/report-store/granulomatosis-with-polyangiitis-market
DelveInsight's "Granulomatosis With Polyangiitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Granulomatosis With Polyangiitis, historical and forecasted epidemiology as well as the Granulomatosis With Polyangiitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market
DelveInsight's "Hemophilia A Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Hemophilia A, historical and forecasted epidemiology as well as the Hemophilia A market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Graft Versus Host Disease Market https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
DelveInsight's "Graft Versus Host Disease (GvHD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Graft Versus Host Disease, historical and forecasted epidemiology as well as the Graft Versus Host Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market
DelveInsight's "Hemorrhoids Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hemorrhoids, historical and forecasted epidemiology as well as the Hemorrhoids market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Asthma Market
https://www.delveinsight.com/report-store/asthma-market
DelveInsight's "Asthma - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan.
Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market
DelveInsight's "Myelodysplastic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Myelodysplastic Syndrome, historical and forecasted epidemiology as well as the Myelodysplastic Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sunovion Pharmaceuticals "LATUDA market size expected to increase many folds by 2032, report DelveInsight here
News-ID: 3456434 • Views: …
More Releases from DelveInsight Business Research
Vitiligo Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA App …
The "Vitiligo Pipeline Insight, 2025" report by DelveInsight delivers an in-depth view of the current clinical development scenario along with the future growth trajectory of the Vitiligo Market.
As per DelveInsight's evaluation, the global Vitiligo treatment pipeline features 20+ leading companies actively engaged in developing 20+ therapeutic candidates. The analysis covers Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and developmental updates.
The Vitiligo Pipeline report offers extensive commercial and clinical…
Myelodysplastic Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Th …
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2025" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Myelodysplastic Syndrome Pipeline Report
• DelveInsight's Myelodysplastic Syndrome…
Fibromyalgia Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA …
According to DelveInsight, the global Fibromyalgia pipeline features more than eight key companies actively developing over ten treatment candidates. The analysis encompasses ongoing clinical trials, therapeutic mechanisms of action, routes of administration, and recent developments within the Fibromyalgia treatment landscape.
The Fibromyalgia Pipeline 2025 report provides an exhaustive evaluation of pipeline products, ranging from preclinical stages to marketed therapies. It includes comprehensive details on each drug's mechanism of action, clinical trial…
Chronic Wounds Competitive Landscape 2025: Clinical Trial Analysis, Therapies, F …
As per DelveInsight's assessment, globally, Chronic Wounds pipeline constitutes 7+ key companies continuously working towards developing 8+ Chronic Wounds treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Chronic Wounds Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic Wounds Market.
The Chronic Wounds Pipeline report embraces in-depth commercial and clinical assessment…
More Releases for LATUDA
Bipolar Depression Market to Exceed USD 11.2 Billion by 2034
Bipolar disorder is a chronic psychiatric condition characterized by alternating episodes of mania/hypomania and depression. Among these, bipolar depression is more frequent, longer-lasting, and associated with greater functional impairment and suicide risk compared to mania. Managing bipolar depression remains a significant challenge, as traditional antidepressants can trigger manic episodes, and treatment options are limited.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71897
The bipolar depression market is expanding due to…
Schizophrenia Market Outlook 2034 - Clinical Trials, Market Size, Medication, Pr …
Schizophrenia Market Size in the 7MM was approximately USD 7,972.0 million in 2022 and is projected to increase during the forecast period (2024-2034).
Schizophrenia Market Summary
In 2022, the US led the 7MM market, valued at USD 5.75 billion, with further growth expected by 2034. The Schizophrenia market is projected to grow steadily from 2024 to 2034, driven by rising disease awareness, improved diagnostics, and the development of more effective treatments. Schizophrenia…
Neuroleptic Drugs Market Size, Share, Growth and Report 2024-2031 | Eli Lily and …
DataM Intelligence has released a new research report on the Neuroleptic Drugs market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits,…
Schizophrenia Market to Grow Positively at a Paltry CAGR During the Study Period …
DelveInsight's "Schizophrenia - Market Insight, Epidemiology and Market Forecast - 2034" report provides current treatment practices, emerging drugs, Schizophrenia market share of the individual therapies, current and forecasted Schizophrenia market size from 2020 to 2034 segmented by seven major markets. The report also offers current Schizophrenia therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the…
Uncovering Novel Drug Candidates for Bipolar Depression: Market Forecast and Ins …
The Latuda market forecast report provides analysis of Latuda market analysis and forecasts upto 2032 in the major markets. The comprehensive report provides analysis of Latuda market potential and Latuda market share analysis in Bipolar Depression across the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan from 2019 to 2032. It helps you to understand the Latuda mechanism of action, route of administration, dosage and…
Schizophrenia Drugs Market Is Expected To Witness Faster Growth Throughout By Tr …
Acumen Research and Consulting has announced the addition of the "Schizophrenia Drugs Market” report to their offering.
The Schizophrenia Drugs Market Report 2018 is an in depth study analyzing the current state of the Schizophrenia Drugs Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Schizophrenia Drugs Market provides analysis of China market covering the industry trends, recent…
